Endpoints News (@endpts) 's Twitter Profile
Endpoints News

@endpts

The biopharma world is here. Get the industry’s most comprehensive daily news reports at endpts.com/subscribe

ID: 3460109487

linkhttp://endpts.com calendar_today27-08-2015 18:08:04

48,48K Tweet

29,29K Takipçi

77 Takip Edilen

Endpoints News (@endpts) 's Twitter Profile Photo
Endpoints News
@endpts

2 months ago

#ASCO25: Lilly won't run mid-stage cancer trials. Why? If it doesn't work in Phase 1 "it’s not a drug in our eyes", says Jake Van Naarden. endpts.com/phase-3-or-bus…